Skip to content
Use caution Drug recall · FDA · Published June 29, 2016

Isomeric Recalls Methylprednisolone/Lidocaine Injections Due to Sterility Issues

Isomeric Pharmacy Solution recalls 274 vials of Methylprednisolone Acetate/Lidocaine HCl injection due to potential difficulty re-suspending particles.

🇺🇸 FDA recall #D-1480-2016DrugIsomeric Pharmacy Solution ›
Take action

Contact the company

Recalling firmIsomeric Pharmacy Solution, LLC2401 S Foothill Dr · Salt Lake City, UT 84109-1479
✎ GovInfoNow plain-language explainer

What happened, in plain English

Isomeric Pharmacy Solution, LLC is recalling specific lots of its compounded Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection. The issue stems from the sterile injectable products being sterilized for too long, which can cause difficulty in re-suspending the particles within the vial. This affects 274 multi-dose vials distributed nationwide and in Puerto Rico. Read more at govinfonow.com/recall/42567-isomeric-recalls-methylprednisolone-lidocaine-injections-due-to-sterility-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/42567-isomeric-recalls-methylprednisolone-lidocaine-injections-due-to-sterility-issues · Updated October 9, 2026 · FDA enforcement record: FDA #D-1480-2016

Cite this page

“Isomeric Recalls Methylprednisolone/Lidocaine Injections Due to Sterility Issues.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42567-isomeric-recalls-methylprednisolone-lidocaine-injections-due-to-sterility-issues. Based on FDA recall #D-1480-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1480-2016%22&limit=1).

Why it’s dangerous

The products were sterilized for an excessive duration, leading to potential difficulty in re-suspending the particles. This could affect the proper administration or efficacy of the medication if the particles do not mix correctly.

Who’s affected

Patients who have received or possess Methylprednisolone Acetate/Lidocaine HCl injection compounded by Isomeric Pharmacy Solution from Salt Lake City, UT. The risk applies to users of lots 03045 and 03046 with an expiration date of 10/16.

How to tell if you have this one

Check for Methylprednisolone Acetate/Lidocaine HCl 40/10 mg/mL Injection in 10 mL multi-dose vials. Look for Lot numbers 03045 or 03046 and an expiration date of 10/16. The product was compounded by Isomeric Pharmacy Solution, LLC in Salt Lake City, UT.

  • Brand
    Isomeric Pharmacy Solution
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Your Healthcare Provider

    If you have received this medication, consult your doctor or pharmacist immediately for guidance on whether to use it or return it.

  2. Verify Lot Numbers

    Check the vial labels for lot numbers 03045 or 03046 and expiration date 10/16 to confirm if your specific product is part of this recall.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico. No Canadian, other foreign, govt/VA/military consignees.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 6 months after the firm started it.

1. Firm started the recall: Jun 29, 201612. FDA classified it Class II: Sep 2, 201623. Published in FDA’s Enforcement Report: Sep 14, 201634. FDA terminated the recall: Dec 20, 201642016
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was this medication distributed?

The recall covers distribution nationwide and in Puerto Rico, excluding Canadian, other foreign, government, VA, or military consignees.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1480-2016 (June 29, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1480-2016 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA